Oncology Times

Proceedings from the American Association for Cancer Research 2018 Annual Meeting

The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, and collaboration. As the largest scientific organization in the world that focuses on pioneering cancer research, it consistently and effectively stays true to this commitment, as evidenced by this year’s annual conference theme, Driving Innovative Cancer Science to Patient Care.

Oncology Times is pleased to report on the latest groundbreaking research presented at the AACR 2018 Annual Meeting, Chicago, IL.

Featured Video

AACR Recap

Key opinion leaders recap the latest research from AACR 2018.

More Videos

 

Featured Articles

Potent & Selective TKI Shows Potential With RET-Altered Cancer Patients

Preliminary proof-of-concept data were presented from an ongoing phase I clinical trial evaluating the use of the next-generation, RET tyrosine kinase inhibitor BLU-667 at the AACR 2018 Annual Meeting.

Read More

 

Immunotherapy Shows Promise Among Lung Cancer Patients

Advances in immunotherapy continue to confirm the power of harnessing the immune system in the treatment of cancer patients.

Read More

 

Pembrolizumab Shows Reduced Risk for Recurrence in Completely Resected Stage III Melanoma

A 1-year course of 18 doses of adjuvant pembrolizumab was shown to significantly reduce the risk of recurrence for stage III melanoma patients that were at high risk of recurrence after surgery.

Read More

 

Risk of Cancers Increased Among Children With Non-Chromosomal Birth Defects

A recent study suggests that children with non-chromosomal birth defects had a significantly higher risk of developing childhood cancer than those who did not have birth defects 

Read More

Loading